The Angeles Clinic and Research Institute Announces Investigational Compound Ipilimumab Demonstrates Improved Overall Su

Los Angeles-based The Angeles Clinic and Research Institute today announced positive results from a Phase 3 randomized, double blind study of ipilimumab which demonstrated that overall survival was significantly extended in patients with previously-… View full post on NewsBlaze.com Current News – California